CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs

被引:346
作者
Mandegar, Mohammad A. [1 ]
Huebsch, Nathaniel [1 ,2 ]
Frolov, Ekaterina B. [1 ]
Shin, Edward [1 ]
Truong, Annie [1 ]
Olvera, Michael P. [1 ]
Chan, Amanda H. [1 ]
Miyaoka, Yuichiro [1 ,12 ]
Holmes, Kristin [1 ]
Spencer, C. Ian [1 ]
Judge, Luke M. [1 ,2 ]
Gordon, David E. [3 ,4 ,5 ]
Eskildsen, Tilde V. [6 ,7 ]
Villalta, Jacqueline E. [3 ,4 ,8 ,9 ]
Horlbeck, Max A. [3 ,4 ,8 ,9 ]
Gilbert, Luke A. [3 ,4 ,8 ,9 ]
Krogan, Nevan J. [3 ,4 ,5 ]
Sheikh, Soren P. [6 ,7 ]
Weissman, Jonathan S. [3 ,4 ,8 ,9 ]
Qi, Lei S. [10 ]
So, Po-Lin [1 ]
Conklin, Bruce R. [1 ,3 ,4 ,11 ]
机构
[1] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Calif Inst Quantitat Biosci, QB3, San Francisco, CA 94158 USA
[5] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA
[6] Univ Southern Denmark, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark
[7] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense C, Denmark
[8] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA
[9] Univ Calif San Francisco, Ctr RNA Syst Biol, San Francisco, CA 94158 USA
[10] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
[11] Univ Calif San Francisco, Dept Med & Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[12] Tokyo Metropolitan Inst Med Sci, Regenerat Med Project, Tokyo 1568506, Japan
基金
加拿大健康研究院;
关键词
PLURIPOTENT STEM-CELLS; TRANSCRIPTION; TALEN; DIFFERENTIATION; EXPRESSION; DISCOVERY; ACCURATE; PLATFORM; DESIGN; MOUSE;
D O I
10.1016/j.stem.2016.01.022
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Developing technologies for efficient and scalable disruption of gene expression will provide powerful tools for studying gene function, developmental pathways, and disease mechanisms. Here, we develop clustered regularly interspaced short palindromic repeat interference (CRISPRi) to repress gene expression in human induced pluripotent stem cells (iPSCs). CRISPRi, in which a doxycycline-inducible deactivated Cas9 is fused to a KRAB repression domain, can specifically and reversibly inhibit gene expression in iPSCs and iPSC-derived cardiac progenitors, cardiomyocytes, and T lymphocytes. This gene repression system is tunable and has the potential to silence single alleles. Compared with CRISPR nuclease (CRISPRn), CRISPRi gene repression is more efficient and homogenous across cell populations. The CRISPRi system in iPSCs provides a powerful platform to perform genome-scale screens in a wide range of iPSC-derived cell types, dissect developmental pathways, and model disease.
引用
收藏
页码:541 / 553
页数:13
相关论文
共 49 条
[1]   Characterization of calcium signals in human embryonic stem cells and in their differentiated offspring by a stably integrated calcium indicator protein [J].
Apati, Agota ;
Paszty, Katalin ;
Hegedus, Luca ;
Kolacsek, Orsolya ;
Orban, Tamas I. ;
Erdei, Zsuzsa ;
Szebenyi, Kornelia ;
Pentek, Adrienn ;
Enyedi, Agnes ;
Sarkadi, Balazs .
CELLULAR SIGNALLING, 2013, 25 (04) :752-759
[2]   Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita [J].
Armanios, M ;
Chen, JL ;
Chang, YPC ;
Brodsky, RA ;
Hawkins, A ;
Griffin, CA ;
Eshleman, JR ;
Cohen, AR ;
Chakravarti, A ;
Hamosh, A ;
Greider, CW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) :15960-15964
[3]   Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR [J].
Boettcher, Michael ;
McManus, Michael T. .
MOLECULAR CELL, 2015, 58 (04) :575-585
[4]   Transcriptional regulatory cascades in development: Initial rates, not steady state, determine network kinetics [J].
Bolouri, H ;
Davidson, EH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9371-9376
[5]   Ultrasensitive fluorescent proteins for imaging neuronal activity [J].
Chen, Tsai-Wen ;
Wardill, Trevor J. ;
Sun, Yi ;
Pulver, Stefan R. ;
Renninger, Sabine L. ;
Baohan, Amy ;
Schreiter, Eric R. ;
Kerr, Rex A. ;
Orger, Michael B. ;
Jayaraman, Vivek ;
Looger, Loren L. ;
Svoboda, Karel ;
Kim, Douglas S. .
NATURE, 2013, 499 (7458) :295-+
[6]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[7]   Current prospects for RNA interference-based therapies [J].
Davidson, Beverly L. ;
McCray, Paul B., Jr. .
NATURE REVIEWS GENETICS, 2011, 12 (05) :329-340
[8]   Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation [J].
Doench, John G. ;
Hartenian, Ella ;
Graham, Daniel B. ;
Tothova, Zuzana ;
Hegde, Mudra ;
Smith, Ian ;
Sullender, Meagan ;
Ebert, Benjamin L. ;
Xavier, Ramnik J. ;
Root, David E. .
NATURE BIOTECHNOLOGY, 2014, 32 (12) :1262-U130
[9]   The new frontier of genome engineering with CRISPR-Cas9 [J].
Doudna, Jennifer A. ;
Charpentier, Emmanuelle .
SCIENCE, 2014, 346 (6213) :1077-+
[10]   ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering [J].
Gaj, Thomas ;
Gersbach, Charles A. ;
Barbas, Carlos F., III .
TRENDS IN BIOTECHNOLOGY, 2013, 31 (07) :397-405